0001389545-26-000001.txt : 20260127 0001389545-26-000001.hdr.sgml : 20260127 20260127124308 ACCESSION NUMBER: 0001389545-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260127 DATE AS OF CHANGE: 20260127 EFFECTIVENESS DATE: 20260127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-571260 FILM NUMBER: 26563534 BUSINESS ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 D 1 primary_doc.xml X0708 D LIVE 0001389545 NovaBay Pharmaceuticals, Inc. 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA CALIFORNIA 94608 (510) 899-8800 DELAWARE None None Corporation true Michael John Kazley 2000 Powell Street, Suite 1150 Emeryville CA CALIFORNIA 94608 Executive Officer Director Chief Executive Officer Other Decline to Disclose 06b false 2026-01-16 false true false 25000000 134000000 134000000 0 false 4 0 0 0 false NovaBay Pharmaceuticals, Inc. Tommy Law Tommy Law Chief Financial Officer 2026-01-27